Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Protoporphyria, Erythropoietic

ClinicalTrials.gov lists 29 trials for Protoporphyria, Erythropoietic or a narrower condition beneath it. Clinuvel Pharmaceuticals Limited has the most among industry and government lead sponsors, with 5.

MeSH D046351 Digestive System Diseases C06 C16 C17 C18 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 5 Phase 2/3 Phase 2/3 3 Phase 3 Phase 3 7 Not applicable Not applicable 5 Observational Observational 6 Expanded access Expanded access 1 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 5 Phase 2/3 Phase 2/3 3 Phase 3 Phase 3 7 Not applicable Not applicable 5 Observational Observational 6 Expanded access Expanded access 1

Trials per phase

29 of the 29 trials are tagged with Protoporphyria, Erythropoietic itself; the rest are tagged with a narrower condition beneath it.

Get the Protoporphyria, Erythropoietic report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Protoporphyria, Erythropoietic trials start? (15)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 3

1996: 2 trials (Not applicable 1, Phase 3 1) 2003: 1 trials (Not applicable 1) 2007: 1 trials (Phase 3 1) 2009: 1 trials (Phase 3 1) 2010: 2 trials (Observational 1, Phase 2 1) 2011: 3 trials (Observational 1, Phase 3 1, Phase 2/3 1) 2012: 3 trials (Observational 1, Not applicable 1, Phase 3 1) 2016: 1 trials (Not applicable 1) 2017: 1 trials (Observational 1) 2018: 1 trials (Phase 2 1) 2022: 3 trials (Observational 1, Phase 2 2) 2023: 3 trials (Not applicable 1, Phase 3 1, Phase 2/3 1) 2024: 1 trials (Phase 1/2 1) 2025: 2 trials (Phase 3 1, Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 2
2024 1
2023 3
2022 3
2018 1
2017 1
2016 1
2012 3
2011 3

No forecast is made for this condition: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Protoporphyria, Erythropoietic trials in? (8)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 5
Phase 2/3 3
Phase 3 7
Not applicable 5
Observational 6
Expanded access 1

How many Protoporphyria, Erythropoietic trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 3
Enrolling by invitation 1
Active, not recruiting 1
Available 1
Completed 19

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Protoporphyria, Erythropoietic trials? (6)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Clinuvel Pharmaceuticals Limited 5
Disc Medicine, Inc 4
Portal Therapeutics, Inc. 3
Tanabe Pharma America, Inc. 2
Clinuvel Europe Limited 1

Which drugs are being tested for Protoporphyria, Erythropoietic? (6)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
RO4917838 5
Afamelanotide 5
cysteine hydrochloride 2
Dersimelagon 1
Cimetidine 1

Interventions as named in the registry (7)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
PORT-77 2
Oral Iron 1
Isoniazida 1
MT-7117 Low Dose 1
Exercise 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Protoporphyria, Erythropoietic trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Diverticulitis 2 2
Abdominal pain 1 1
Abnormal liver enzymes 1 1
Anaphylactic reaction 1 1
CRAMPY ABDOMINAL PAIN 1 1

Which publications cover Protoporphyria, Erythropoietic? (4)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (44)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Autosomal erythropoietic protoporphyria Point prevalence 1-9 / 100 000 United Kingdom GB Exact
Autosomal erythropoietic protoporphyria Annual incidence <1 / 1 000 000 United Kingdom GB Exact
Autosomal erythropoietic protoporphyria Point prevalence 1-9 / 100 000 United Kingdom GB Exact
Autosomal erythropoietic protoporphyria Annual incidence <1 / 1 000 000 United Kingdom GB Exact
Autosomal erythropoietic protoporphyria Annual incidence <1 / 1 000 000 Sweden Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Autosomal erythropoietic protoporphyria 79278 Exact Orphanet Rare Disease Ontology (ORDO)
Autosomal erythropoietic protoporphyria 79278 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages